GHIT Fund invests $8.5 million in five Global R&D Projects for malaria and NTD drugs
The GHIT Fund has committed JPY 1.37 billion (USD 8.5 million) to five R&D projects targeting malaria and neglected tropical diseases, including preclinical antimalarial development and multi-country trials for eumycetoma treatment fosravuconazole.